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Chiral Antioxidant-based Gold 
Nanoclusters Reprogram DNA 
Epigenetic Patterns
Yue Ma1, Hualin Fu1,2, Chunlei Zhang1, Shangli Cheng1, Jie Gao1,3, Zhen Wang1,4, Weilin Jin1,2, 
João Conde5,6 & Daxiang Cui1,2
Epigenetic modifications sit ‘on top of’ the genome and influence DNA transcription, which can force 
a significant impact on cellular behavior and phenotype and, consequently human development and 
disease. Conventional methods for evaluating epigenetic modifications have inherent limitations 
and, hence, new methods based on nanoscale devices are needed. Here, we found that antioxidant 
(glutathione) chiral gold nanoclusters induce a decrease of 5-hydroxymethylcytosine (5hmC), which 
is an important epigenetic marker that associates with gene transcription regulation. This epigenetic 
change was triggered partially through ROS activation and oxidation generated by the treatment 
with glutathione chiral gold nanoclusters, which may inhibit the activity of TET proteins catalyzing 
the conversion of 5-methylcytosine (5mC) to 5hmC. In addition, these chiral gold nanoclusters can 
downregulate TET1 and TET2 mRNA expression. Alteration of TET-5hmC signaling will then affect 
several downstream targets and be involved in many aspects of cell behavior. We demonstrate for the 
first time that antioxidant-based chiral gold nanomaterials have a direct effect on epigenetic process of 
TET-5hmC pathways and reveal critical DNA demethylation patterns.
Gold nanoparticles have been extensively exploited for potential biomedical applications due to their extraordi-
nary optical and electronic properties, presenting several shapes such as nanorods, nanoshells, nanospheres and 
nanocages1,2. Composed of a few to a hundred atoms, the size of gold nanoclusters (AuNCs) is comparable to the 
de Brogliewavelength at the Fermi level, resulting in molecule-like properties including discrete electronic states 
and size-dependent fluorescence. High stability, biological compatibility, diverse sizes and easy surface function-
alization have made AuNCs ideal platform for biomedical applications, such as cancer diagnostics, therapy and 
bioimaging3–12.
Although the cytotoxicity of nanoparticles have been extensively assessed13–15, the underlying mechanism 
of toxicity induced by nanoparticles remains to be fully elucidated. It has been reported that the toxicity of gold 
nanoparticles is dependent on the chemical composition of the surface ligands16 and size of the nanoparticles13. 
However, the knowledge of how cells interact with this class of ultra-small nanoparticles remains underexplored, 
especially the effect of AuNCs on epigenetics regulation.
Epigenetics refers to the changes of gene expression caused by external or environmental factors other than 
changes in the DNA sequence, some of which are heritable17–19. DNA methylation is one of the main epigenetic 
modifications. Perturbed DNA methylation patterns are associated with many human diseases such as cancer20, 
neurological disorders21 etc. The enzymes that catalyze DNA methylation such as DNMTs have been well stud-
ied. The ten-eleven translocation (TET) family of 5-mC hydroxylases includes TET1, TET2 and TET3. The TET 
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proteins have been shown to function in transcriptional activation and repression (TET1), tumor suppression 
(TET2), and DNA methylation reprogramming processes (TET3). The discovery of TET proteins has shed light 
on the DNA demethylation mechanism, which is an exciting advance in the epigenetic field. TET proteins are 
capable of catalyzing the oxidation of 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC) in mam-
malian DNA22,23. 5hmC is an important marker in epigenetics, which is mainly involved in up-regulation of gene 
expression associated with cell differentiation, neuronal development and aging21.
Among the thiolate protected Au NCs, chiral L-glutathione (i.e. L-GSH; N-γ -glutamyl-cysteinyl-glycine), a 
naturally occurring tripeptide, which intensively exists in living cells to maintain the reducing state of cellular 
potential and to protect biological molecules against oxidative damage, was mainly used as the thiolate ligand for 
the synthesis of AuNCs24. It is evident that the ligand shell can tune the (bio)chemical properties and exert a tre-
mendous influence on the applications of thiolate-protected gold nanoclusters. So we choose L-GSH and D-GSH 
as the capping ligands of Au NCs.
Here we showed for the first time that antioxidant-based chiral AuNCs capped with GSH enantiomers - 
L-GSH or D-GSH have a strong effect on 5hmC levels and gene expression regulation (specially the L-GSH 
AuNCs), which emphasizes the important effect on epigenetics by nanomaterials. These antioxidant-based chiral 
AuNCs can down-regulate the mRNA expression level of TET1 and TET2, and also induce the aggregations of 
TET proteins through oxidation of their catalytic domains. These alterations can result in the decreasing of the 
catalytic activities of TET proteins and the subsequent global decline of 5hmC levels, which leads to gene expres-
sion changes that are involved in cell adhesion, migration, proliferation, differentiation and cell apoptosis. This 
demethylation process is necessary for epigenetic reprogramming of genes and is also directly involved in many 
important disease mechanisms such as tumor progression.
Characterization of glutathione-based chiral gold nanoclusters
Antioxidant-based chiral AuNCs capped with enantiomers of L-GSH or D-GSH (N-γ -D-glutamyl-D-cysteinyl- 
glycine) were used to actively regulate epigenetic events associated with DNA demethylation processes, which is 
the removal of a methyl group (Fig. 1a). The demethylation process is necessary for epigenetic reprogramming of 
genes and is also involved in several key disease mechanisms such as cancer progression. Commonly the removal 
of 5-methylcytosine occurs via the sequential modification of cytosine bases that have been converted by TET 
enzyme-mediated oxidation. Here we designed smart glutathione-based chiral gold nanoclusters to tackle this 
mechanism and reprogram key driver genes involved in cell adhesion, migration, proliferation, differentiation 
and cell apoptosis. The synthesis of AuNCs@L-GSH was performed using TBAB: tetrabutylammonium borohy-
dride (Fig. 1b). High-resolution TEM images (Fig. 1c) and size distribution (Fig. 1d) of AuNCs@L-GSH revealed 
that these nanoclusters present a well disperse distribution with approximately 4–5 nm in diameter.
Next, the biocompatibility of the glutathione-based chiral gold nanoclusters designed here was evaluated 
in order to define the best nanoformulation to evaluate and reprogram epigenetics patterns. Cytotoxicity of 
L- and D-GSH-capped AuNCs was determined using the MTT colorimetric assay (Fig. 1e). AuNCs@L-GSH 
displayed minimal toxicity at dose up to 250 μ g/ml against human gastric cancer cell line (MGC-803), with an 
IC50 (half-maximum inhibitory concentration) of 1068.6 ± 59.2 μ g/ml (Fig. 1e). Conversely, AuNCs@D-GSH 
induced a significant decrease in cell viability with doses up to 1000 μ g/ml. The IC50 values for the viability of 
cells treated with AuNCs@D-GSH is 87.3 ± 3.4 μ g/ml. Furthermore, the apoptosis mechanisms of MGC-803 cells 
treated with AuNCs@L-GSH and AuNCs@D-GSH were evaluated and compared using an Annexin V-FITC/
Propidium Iodide double staining method. The percentage of cells in early and late apoptotic, as well as necrotic 
stages in MGC-803 cells exposed to 100 μ g/ml of AuNCs@L-GSH and AuNCs@D-GSH for 24 h was quantified 
by flow cytometry (Fig. 1f). The majority of cells undergo apoptosis (approximately 14% for early apoptosis, 48% 
for late apoptosis) rather than necrosis when exposed to AuNCs@D-GSH, while only around 13% and 3% of 
cell death was due to early and late apoptosis when exposed to AuNCs@L-GSH (Fig. 1f). These results are con-
sistent with the decrease in cell viability of MGC-803 cells treated with AuNCs@D-GSH, when compared with 
AuNCs@L-GSH.
It is expected that the toxicity of nanoparticles has an intimate relationship to their uptake and intracellu-
lar distribution. The nanoparticle size, surface area, and surface functionalization are major factors that influ-
ence toxicity25,26. Although the results in Fig. 1e show that both L-GSH capped AuNCs and D-GSH capped 
AuNCs cause cytotoxicity in MGC803 cells at higher concentrations, there was little cytotoxicity at a low con-
centration for AuNCs@L-GSH. Therefore, since the AuNCs@L-GSH used in this study showed less cytotoxic 
than the AuNCs@D-GSH, the enantiomer L-GSH was the one used in the following epigenetic studies. The 
AuNCs@L-GSH were synthesized using tetrabutylammonium borohydride(TBAB)27 (Fig. 2c) and exhibit 
a spherical shape (Fig. 2d) and an outstanding size uniformity (Fig. 2e). The AuNCs@L-GSH displayed good 
bio-compatibility and were proved to be stable in PBS and DMEM at 37 °C for 24 h. Microscopic observations of 
monolayer cultured MGC-803cells and HEK 293FT cells did not show obvious morphological changes compar-
ing to the controls until the final concentration up to 1,000 μ g/mL. No toxicity was observed when the MGC-803 
cells and HEK 293FT cells were treated with a final concentration up to 500 μ g/mL of AuNCs@L-GSH.
Glutathione-based nanoclusters reduce 5-Hydroxymethylcytosine levels
In order to evaluate if glutathione-based chiral gold nanoclusters can alter 5-Hydroxymethylcytosine (5hmC) 
levels, HEK293FT cells (Fig. 2a) and MGC-803 cells (Fig. 2c) were transfected with a control or a TET1 expres-
sion plasmid respectively. Then the cells were treated by adding increasing doses of AuNCs@L-GSH during 48 h. 
Total DNA was extracted and a dot blot assay was performed to analyze possible changes in 5hmC levels. The 
nylon membranes were stained with methylene blue for total DNA as a loading control (Fig. 2a,c). We found that, 
using densitometry quantification (Fig. 2b,d), the levels of 5hmC were significantly down-regulated (p < 0.01) by 
exposure to 100 μ g/mL of AuNCs@L-GSH in both cell lines, when comparing cells transfected with a control or 
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a TET1 expression plasmid. In addition, the 5hmC levels decreased gradually with increasing AuNCs@L-GSH 
concentrations (p < 0.01). These results indicate that chiral gold nanoclusters may be related with a reduce 
5-Hydroxymethylcytosine (5hmC) levels, which is known as the “Sixth base” of DNA that infiltrates into the 
major groove of DNA and regulate transcription.
Figure 1. Characterization of L-GSH capped AuNCs and evaluation of its cytotoxicity, when compared 
with its enantiomer D-GSH capped AuNCs. (a) Regulation of epigenetic events associated with DNA 
demethylation processes, which is the removal of a methyl group, using antioxidant-based chiral AuNCs capped 
with enantiomers of L-GSH or D-GSH (N-γ -D-glutamyl-D-cysteinyl-glycine). (b) Schematic of the synthesis 
of AuNCs@L-GSH.TBAB: tetrabutylammonium borohydride. (c) High-resolution TEM image of AuNCs@L-
GSH. Scale bar = 10 nm. (d) Size distribution of AuNCs@L-GSH. (e) Cell viability (MTT assay) for MGC-803 
cells treated with AuNCs@L-GSH and AuNCs@D-GSH, the data were normalized to control group (cells 
cultured in normal media). (f) Flow cytometry analysis of apoptosis/necrosis in MGC-803 cells after exposure 
to 100 μ g/ml of AuNCs@L-GSH and AuNCs@D-GSH for 24 h. FL1-H axis represents cells stained with 
Annexin-V FITC dye. FL2-H represents cells stained with propidium iodide (PI) dye. All experiments were 
done in triplicates and errors reported as standard deviation (s.d.).
www.nature.com/scientificreports/
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TET proteins catalyze conversion of 5mC to 5hmC
TET1, TET2 and TET3 are a family of Fe2+ and α -ketoglutarate (α -KG) dependent dioxygenases, which can 
utilize molecular oxygen to transfer a hydroxyl group to 5mC to generate 5hmC22,23,28,29. 5hmC is the first oxi-
dative product in the multistep-reaction of 5mC demethylation catalyzed by TET proteins. Studies have shown 
that TET proteins can further catalyze the sequential conversion of 5hmC to 5-formylcytosine (5fC) and 
5-carboxylcytosine (5caC), and these 5mC derivatives can be further modified by thymine-DNA glycosylase 
(TDG) and excised by base excision repair or by replication-dependent dilution, resulting in DNA demethyla-
tion30,31 (Fig. 3a).
Human TET1 and TET3 proteins contain an amino-terminal CXXC domain and a carboxy-terminal catalytic 
domain (CD domain), which consist of a Cys-rich domain and a double-stranded β -helix (DSBH) domain. It is 
worth noting that CXXC domain of TET2 is lost during evolution32,33 (Fig. 3b).
We next validated that CD domain of TET1 can catalyze the conversion of 5mC to 5hmC (Fig. 3c). Ectopic 
expression of TET1 full-length protein in HEK 293FT cells causes an increase in 5hmC levels, which is abrogated 
by mutation of CD domain (Fig. 3c), whereas the Δ CXXC mutant still possesses the dioxygenase activity.
Glutathione-based nanoclusters regulate gene expression associated with 5hmC  
and TET
The previous experiments showed that AuNCs@L-GSH treatment reduces global 5hmC in MGC-803 and HEK 
293T cells. And we validated the conversion of 5mC to 5hmC is catalyzed by TET protein, which is consistent 
with the previously reported22. Since the association of AuNCs@L-GSH in TET mRNA expression and associated 
genes is not clear, these cells were treated with 0, 200 and 500 μ g/mL AuNCs@L-GSH for 24 h and the genetic 
expression profile of treated cells was performed. As the gene expression profile of a cell determines its phenotype 
and its response to various factors and therapies, a genome wide expression array (human transcriptome array 
Figure 2. Dot blot for 5hmC of HEK 293FT cells and MGC-803 cells treated with indicated concentration 
of AuNCs@L-GSH. HEK 293FT cells and MGC-803 cells were transfected with a control vector and with TET1 
expression plasmids and then treated with increasing concentrations of AuNCs@L-GSH for 48 h. Total DNA 
was harvested and Dot blot was conducted for 5hmC in HEK 293FT cells (a) and MGC-803 cells (c). The nylon 
membranes were stained with methylene blue for DNA as loading control. The densitometry quantification was 
analyzed as in (b,d) for HEK 293FT cells and MGC-803 cells, respectively. Data are expressed as mean ± SEM. 
Statistical comparisons between groups were conducted by unpaired Student’s t-test. P-values were shown in the 
figure. *indicates p < 0.05; **indicates p < 0.01; ***indicates p < 0.001. The value of p < 0.05 was considered to 
be significant.
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Affymetrix Human HTA2.0) was performed in cells treated with AuNCs@D-GSH and AuNCs@L-GSH and in 
cells with no treatment (control). Differentially expressed genes were screened out through fold change. The 
threshold set for up- and down-regulated genes was a fold change greater than or equal to 1.5. There were 392 
differentially expressed genes in total in combination of AuNCs@L-GSH vs. control and AuNCs@D-GSH vs. 
control (Fig. 4d).
For gene expression heat-maps (Fig. 4a) the average expression across three independent replicates in each 
condition basing on the probes with the maximum signal intensity per gene was calculated. Heat maps were 
created using Genesis 1.7.639 based on Pearson correlation coefficients of each replicate per condition. Pathway 
analyses were performed using Gene Set Enrichment Analysis tool v2.0.13 (GSEA2-2.0.13). The analyses were 
based on differentially expressed genes in each group. Differential expression was defined as multiple testing 
adjusted p values smaller than or equal to 0.05 and fold change greater than or equal to 1.5-fold by probes with 
Figure 3. TET proteins catalyze demethylation of 5mC. (a) Illustration of TET protein catalyzing 5mC, 
5hmC, 5fC and 5caC conversion. (b) Schematic of TET proteins structure. (c) Immunostaining of TET1 and 
5hmC in HEK 293FT ectopic expressing Flag tagged TET1-FL (TET1 full-length), TET1-Δ CXXC (TET1 
mutation with CXXC domain deletion) and TET1-CD mut (TET1 with CD domain mutation). DAPI stains the 
nucleus. Scale bar = 100 μ m.
www.nature.com/scientificreports/
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Figure 4. Glutathione-based chiral gold nanoclusters regulate gene expression associated with 5hmC and 
TET. MGC-803 cells were treated with indicated concentrations of AuNCs@L-GSH and AuNCs@D-GSH for 
12 h, the cells cultured in normal media were denoted as control group. (a) Heat-map for Gene Expression 
Array of cells treated with 100 μ g/mL AuNCs@L-GSH and AuNCs@D-GSH. (b) Pathway analysis based on 
KEGG of significantly altered genes after treatment with AuNCs@L-GSH and AuNCs@D-GSH. (c) qRT-PCR 
of relative TET mRNA levels for AuNCs@L-GSH treated samples comparing to control. ACTB (beta-actin) was 
served as a reference gene. Data are expressed as mean ± SEM. Statistical comparisons between groups were 
conducted by one-way ANOVA followed by a Newman-Keuls comparison test. P-values were shown in the 
figure. *indicates p < 0.05; **indicates p < 0.01; ***indicates p < 0.001. The value of p < 0.05 was considered to 
be significant. (d) Venn diagram shows the intersectional genes associated with 5hmC, TET1 and TET2 from 
relevant database and gene chips for AuNCs@L-GSH treated samples. Databases refer to the gene chip data 
from references containing 5hmC related differentially expressed genes35 (NCBI GEO accessions: GSE38118) 
combined with TET related genes36 (NCBI GEO accessions: GSE50198 and GSE50200). (e) qRT-PCR to validate 
the gene expression changes in (a).
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the maximum intensity in each gene. A clustergram of genes that are differentially regulated by application of 
AuNCs@D-GSH vs. control and for AuNCs@L-GSH vs. control was built (Fig. 4a) as previously described34. 
The data were analyzed by unsupervised hierarchical clustering, which revealed that the two treatment groups 
had distinct gene expression profiles. Using a threefold change relative to the control group (no treatment) as a 
criterion for differential expression, numerous genes were extracted from the administration of the two different 
nanoclusters (AuNCs@D-GSH and AuNCs@L-GSH).
Detailed Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was used to identify the 
molecular pathways and describe the biological processes of the transcript profiling data. Based on the Gene 
Ontology (GO) analysis, the GO terms of “biological process” that were significantly over-represented in each 
cluster of the heat maps are shown in Fig. 4b. The significant GO terms of the altered genes for cells treated with 
AuNCs@D-GSH belong to multiple pathways mainly related with metabolism, immune disease and translation 
processes. However, for cells treated with AuNCs@L-GSH molecular pathways were related mainly with apopto-
sis, signal transduction and protein folding. These observations indicate that the characteristics of the upregulated 
genes and downregulated genes resulting from the different treatments were completely different.
In order to evaluate the effect of AuNCs@L-GSH, cells were then harvested and total mRNA was extracted, 
followed by RT-qPCR to test TET mRNA levels. The results show dramatic decline in TET1 (p < 0.001) and TET2 
(p < 0.01) mRNA levels, whereas TET3 mRNA presents little changes, suggesting that AuNCs@L-GSH mainly 
affect the mRNA of TET1 and TET2 genes (Fig. 4c).
Previous studies prove that TET proteins play a key role in regulating gene transcription, embryonic develop-
ment and tumorigenesis. The molecular events involved in changing TET activity may be associated with tumor-
igenesis by regulating gene expression. Our results showed that AuNCs@L-GSH mainly affected TET1 and TET2 
mRNA, causing a dramatic decline in global 5hmC levels. 5hmC is enriched at both the start sites of actively tran-
scribed genes and extended promoter regions of Polycomb-repressed genes. We then screen and cross-referenced 
several genes associated with 5hmC, and TET1 or TET2 from databases and the gene chips (from Fig. 4) or pre-
vious published papers27 to validate their expression changes (Fig. 4d). The databases contain the gene chip data 
from references containing 5hmC related differentially expressed genes35 (NCBI GEO accessions: GSE38118) and 
TET related genes36 (NCBI GEO accessions: GSE50198 and GSE50200).
The qRT-PCR results show that TWIST2 and HBP1 were up-regulated, whereas TRPC4, SH3, CREBRF, 
FBXO32, HMOX1, KLHL24, NRID2, SESN2, SEMA6D, SCLC7A11 and ID1were down-regulated in 
AuNCs@L-GSH treated samples (Fig. 4e).
HBP1 was up-regulated through AuNCs@L-GSH treatment, which encodes a transcriptional repressor with a role 
in cell cycle arrest37, suggesting that AuNCs@L-GSH may regulate cell cycle. CREBRF (CREB3 regulatory factor) has 
been reported to negatively regulate the endoplasmic reticulum (ER) stress response (or unfolded protein response)38. 
In the lumen of ER, unfolded proteins may cause stress response of the ER which is initially for damage repair but 
can eventually trigger cell death if ER dysfunction is severe39. Actually, in nanogold particles treated human chronic 
myelogenous leukemia cells, ER stress responses was elicited through biology analysis of the proteomic data40. ID1 is a 
member of ID genes, which encode transcription factors that play important roles in regulation of cell adhesion, migra-
tion, growth, proliferation, differentiation and tumorigenesis41–44. It has been reported that ID genes expression were 
down-regulated both in cell lines and in the liver tissues of mice treated with iron nanoparticles45.
Glutathione-based nanoclusters cause TET proteins aggregation
As we have discussed above, TET proteins belong to a class of α -KGand Fe2+-dependent dioxygenases which 
catalyze an oxidative process. There is a long-standing view that nanoparticle triggered ROS production 
is one of the principal mechanisms of cytotoxicity. The intracellular ROS levels may also affect TETs activity 
through oxidation effects. In order to evaluate if glutathione-based chiral gold nanoclusters could generate ROS, 
Dihydroethidium (DHE) dye staining and cellular uptake was used (Fig. 5a). MGC-803 cells were treated with 
increasing concentrations of AuNCs@L-GSH for 12 h, and then DHE staining was performed to detect ROS 
levels. We found that, using fluorescent densities quantification, the ROS levels gradually increase as the concen-
tration of AuNCs@L-GSH rises up, exhibiting significant differences (p < 0.05) when the concentration reached 
200 μ g/mL (Fig. 5b). Next, to validate if AuNCs@L-GSH could also affect TET1 proteins through generating ROS 
a redox-western blot assay was performed. HEK 293FT cells were transfected with GFP-TET1 expression plas-
mid46,47 and treated with 0, 200 and 500 μ g/mL AuNCs@L-GSH for 12 h respectively, and 1 mM H2O2 treatment 
as positive control. We found that the TET1 protein complex formation occurs under non-reducing conditions as 
well as with H2O2 treatment (Fig. 5c), suggesting that AuNCs@L-GSH could induce TET protein complex forma-
tion in non-reducing conditions, and then affect their enzymatic activities through ROS generation.
Glutathione-based chiral gold nanoclusters trigger intracellular ROS generation
Reactive oxygen species refer to a group of chemically reactive molecules such as superoxide anion (O2• − ), 
hydroxyl radicals (• OH) and hydrogen peroxide (H2O2), that is continually generated through aerobic cellular 
metabolism and may function as signaling molecules, regulating cell vitality, proliferation, migration and dif-
ferentiation48. However, excess ROS may impair cellular functions. We have previously proved that GSH capped 
AuNCs can induce intracellular ROS generation previously49. In the present study, we used H2O2 treatment as 
a positive control to study the ROS regulation on TET proteins and mRNAs. Cellular ROS levels were detected 
with DHE. Cultured MGC-803 cells were treated with 50 μ M and 200 μ M H2O2 for 0.5 h, and then were probed with 
DHE to visualize ROS levels. Epi-fluorescence images displayed that cellular fluorescent density is positively corre-
lated with the amount of H2O2 added (Fig. 6a,b). Next, we examined TET mRNA expressions and found that the 
levels of TET mRNA were significantly decreased (p < 0.05) with increasing H2O2 concentrations (Fig. 6c), suggest-
ing that TET protein have a decreased activity under oxidative stress, probably via inhibition of demethylase activity.
www.nature.com/scientificreports/
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Redox western blots were then performed to examine the forms of TET proteins with a fixed concentration 
of H2O2 treatment under reduced and non-reduced conditions, respectively. We found that TET1,TET2 and 
TET3 proteins show electrophoretic mobility shift in non-reduced conditions, suggesting that the TET proteins 
can form large aggregations (termed TET1 complex, TET2 complex and TET3 complex) mediated by oxidation 
processes (Fig. 6d).
Considering that the TET proteins own a Cysteine-rich domain in their C-terminal, which play essential 
roles in their catalytic activities, we speculate that oxidative aggregation may result from oxidation in cysteine 
thiol groups (R-SH), and further formation of inter- or intra-molecular disulfides between other thiol groups. 
To test our hypothesis, HEK 293FT cells were transfected with two kinds of TET1 truncation, TET1-Δ CXXC 
(CXXC domain deletion) and TET1-CD (only CD domain), and treated with a fixed concentration of H2O2. Both 
TET1-Δ CXXC and TET1-CD truncations can form aggregations under non-reducing conditions, indicating that 
the CD domain of TET1 was involved in the formation of larger TET1 protein complex (Fig. 6e). The intracellular 
ROS levels were indicated by the positive control Prdx-SO350 (Fig. 6f). Since CD domains of TET proteins are 
essential for the enzymatic activities, large TET protein complex caused by ROS-induced excessive oxidation in 
CD domain may impair their function, which decreases the global level of 5hmC in the cells.
Although some potential functions of DNA methylation have been demonstrated already in previous studies, 
numerous questions remain in terms of unveiling the role of 5hmC. Here we prove that 5hmC serves both as an 
intermediate of DNA demethylation as well as a stable epigenetic marker.
Conclusions
In the present study, we first demonstrated that AuNCs@L-GSH not only cause cytotoxicity at high doses, but also 
change the 5hmC levels at non-cytotoxic doses. As corroborated by our data, 5hmC can influence both long and 
short-term regulation of gene expression, which will likely have biological significance in vivo. We then found that 
the non-cytotoxic AuNCs@L-GSH can down-regulate the mRNA expression level of TET1 and TET2, and also 
induce the aggregations of TET proteins through oxidation of their catalytic domains. These alterations can result 
in the decreasing of the catalytic activities of TET proteins and the subsequent global decline of 5hmC levels, 
which leads to gene expression changes that are involved in cell adhesion, migration, proliferation, differentiation 
and cell apoptosis.
Figure 5. AuNCs@L-GSH cause TET1 protein aggregation. (a)MGC-803 cells were treated with indicated 
concentrations of AuNCs@L-GSH for 24 h. DHE staining was performed to label the ROS levels of MGC-
803 cells. (b) Densitometry quantification of cell fluorescence stained by DHE in (a). Data are expressed as 
mean ± SEM. Statistical comparisons between groups were conducted by unpaired Student’s t-test. P-values 
were shown in the figure. *indicates p < 0.05; **indicates p < 0.01. The value of p < 0.05 was considered to be 
significant. (c) HEK 293FT cells were transfected with GFP tagged TET1 expression plasmid and then treated 
with 0, 200 and 500 μ g/mL AuNCs@L-GSH respectively for 12 h. Then redox-western blot was performed to 
detect the GFP-TET1 in reduced and non-reduced condition. Treatment with 1 mM H2O2 for 5 min was chosen 
as a positive control.
www.nature.com/scientificreports/
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Since low-cytotoxic or non-cytotoxic dosages of AuNCs have been widely used in biomedicine, our data 
proved that even a non-cytotoxic dose of AuNCs@L-GSH has the potential to cause epigenetic changes as ana-
lyzed by 5hmC and TET mRNA levels, which raise the concern about the safety associated with applications of 
the AuNCs in particular and nanomaterials in general. Further studies must be conducted in this field to achieve 
a deeper understanding of the physiological and (epi)genetic effects of AuNCs. These findings suggest that with 
Figure 6. ROS regulates TET mRNA expression and TET protein activities. (a) DHE staining to evaluate 
ROS levels in MGC803 cells treated with indicated concentrations of H2O2. Scale bar = 100 μ m.(b) Relative 
fluorescent density of cells stained by DHE in (a). Statistical comparisons between groups were conducted 
by unpaired Student’s t-test. P-values were shown in the figure. *indicates p < 0.05; ***indicates p < 0.01. (c) 
qRT-PCR was performed to test relative TET mRNA expression of MGC-803 cells treated with indicated 
concentration of H2O2. ACTB was chosen as a loading control. Data are expressed as mean ± SEM. Statistical 
comparisons between groups were conducted by one-way ANOVA followed by a Newman-Keuls comparison 
test. P-values were shown in the figure. *indicates p < 0.05; **indicates p < 0.01. The value of p < 0.05 was 
considered to be significant.(d) HEK 293FT cells were transfected with GFP-tagged TET1, Flag-tagged TET2 
and Flag-tagged TET3 expression plasmid respectively and cultured for 24 h, then the cells were treated with 
indicated final concentrations of H2O2 for 5 min. Cells were lysed in reduced and non-reduced conditions 
followed by western blot analysis. Molecular weights were determined by a simultaneously run protein ladder. 
(e) HEK 293FT cells ectopic expressing GFP-tagged TET1-Δ CXXC (TET1 mutation with CXXC domain 
deletion) and HA-tagged TET1-CD (TET1 mutation with only CD domain) were treated with H2O2 at indicated 
concentrations for 10 min respectively. Lysates were analyzed by western blot with GFP and HA antibody under 
reducing or non-reducing conditions. (f) The oxidative stress induced by H2O2 was indicated by Prdx-SO3 level 
as a positive control.
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the increasing translational applications of gold nanoparticles from the benchtop to the clinic, researchers should 
carefully evaluate all aspects of biosafety, especially in genetics and epigenetics.
Methods
Synthesis and characterization of glutathione-capped chiral AuNCs. In a typical synthesis, freshly 
prepared aqueous solutions of HAuCl4 (10 mM, 10 ml) and GSH (L-GSH or D-GSH; 150 mM, 2 ml) were mixed 
and stirred for 20 min at room temperature. The reaction mixture was then cooled down to 0 °C (ice-bath), and 
subsequently, tetrabutylammonium borohydride (5 equiv/mol of Au, 3 ml) was added rapidly and then stirred 
quickly for 4 h. A side-product of the insoluble substance was identified to be Au(I)-SG complexes27. The super-
natant was further purified by adding three times amount of ethanol into the aqueous solution and centrifuge 
at 10,000 rpm for 15 min. Under such condition, the Au NCs were precipitated out of the solution while the free 
GSH and gold ions remained in the solution. The precipitates were then re-suspended in ultrapure water and 
stored at 4 °C for further experiments.
The size and morphologies of the Au NCs were characterized by High-resolution TEM (HRTEM) on JEM-
2100F (JEOL, Japan) with an acceleration voltage of 200 kV. UV-vis spectra were measured with a Varian Cary 
50 spectrophotometer (Varian Inc., Palo Alto, CA, USA) equipped with a 10-mm quartz cell, where the light 
path length was 1 cm. Photoluminescence (PL) and photoluminescence excitation (PLE) spectra of Au NCs 
were recorded on a Hitachi FL-4600 spectrofluorometer. Circular dichroism (CD) measurements of Au NCs 
were performed on a Jasco J-815 CD spectrometer (Jasco International, Tokyo, Japan) in quartz cuvettes with 
a path length of 10 mm at room temperature. Data were collected every 0.2 nm with a bandwidth of 1 nm, 
at 50 nm min−1 and aver- aging over three scans. Size distribution and zeta potential of Au NCs were deter-
mined by dynamic light scattering using a NICOMP 380 ZLS Zeta potential/Particle sizer (PSS Nicomp, Santa 
Barbara, CA, USA).
Cell culture and cell viability assay. The human gastric cancer cell line MGC-803 cells were obtained 
from the Cell Resource Center, Shanghai Institute of Biochemistry and Cell Biology at the Chinese Academy 
of Sciences, and human embryonic kidney cell line HEK 293FT cells were purchased from Invitrogen51. These 
cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM, Life Technologies) with 10% fetal bovine 
serum (Gibco), 100 U/mL penicillin and 100 μ g/mL streptomycin (Life Technologies) at 37 °C in a humidified 5% 
CO2 atmosphere. Cell viability was detected by the 3-[4, 5-dimethyl-2-thiazolyl]-2, 5-diphenyl-2-H-tetrazolium 
bromide (MTT) assay. Briefly, cells were seeded at a density of 5 × 103 cells/well in a 96-well plate and cultured 
overnight. The cells were incubated with various concentrations of AuNCs for 24 h. The supernatant was then 
removed and cells were washed once with phosphate-buffered saline (PBS) (pH 7.4). 150 μ L DMEM and 15 μ 
L MTT (0.5 mg/mL) were added to each well and incubated for 4 h at 37 °C. After removing the medium, 150 μ 
L DMSO was added to each individual well. Following complete dissolution for 10 min at room temperature, 
the absorbance was measured at 570 nm using a standard micro plate reader (Scientific MultiskanMK3, Thermo 
Scientific, USA).
Cell transfection, immunostaining and 5hmC staining. Cells were transfected using X-tremeGENE 
HP DNA transfection reagent (Roche) according to the manufacture’s protocol.
For immunostaining, HEK 293FT cells cultured on poly-L-Lysine coated glass coverslips were fixed with 4% 
paraformaldehyde for 15 min at room temperature and then treated with ice-cold methanol for 10 min at − 20 °C. 
After being blocked by 15% donkey serum for 30 min, cells were incubated with primary antibody at 4 °C over-
night. After incubation with the primary antibody, the cells were incubated for 1 h at room temperature with 
Alexa Fluor-labeled secondary antibodies (1:800; Molecular Probes, Leiden, The Netherlands). Then, the covers-
lips were mounted with glycerine/PBS containing 5 μ g/mL DAPI for nuclei staining.
For 5hmC staining, the fixed cells were denatured in 2 M HCl at 37 °C for 20 min–30 min, then were neutral-
ized in 100 mM Tris-HCl (pH 8.0) at 37 °C for 2 times, each time for 10 min. After neutralization, the cells were 
blocked in BSA with 15% donkey serum and incubated with 5-Hydroxymethylcytosine (5hmC) antibody (1:500; 
Active Motif) at 4 °C overnight and then stained in secondary antibodies and the coverslips were mounted as 
described above.
Quantitative Real-time PCR. Total RNA was extracted using TRIZOL (Invitrogen) following the manu-
facturer’s protocol. The cDNAs were generated from 1 μ g of total RNA using reverse transcriptase with random 
hexamer and oligo dT primers (Promega). Quantitative real-time PCR was performed using specific primers 
(List in Table S1) in a 20 μ L reaction volume containing 10 μ L 2 × SYBR Green Mix (GeneCopoeia) on the iQ5 
(BioRad).
Dot-blot assay. HEK 293FT cells were transfected with X-tremeGENE HP DNA transfection reagent 
(Roche) and pEGFP-N1 and GFP-TET1 plasmids respectively according to the manufacture’s protocol in 
35 mm-diameter culture dishes. After 4 hours of transfection, different doses of AuNCs were added to the dishes 
at various final concentrations as follows: 0, 10, 30, 100, 200 and 500 μ g/mL. Cells were harvested 48 hours after 
transfection. The genomic DNA was isolated using the EZNA Tissue DNA kit (OMEGA). For dot-blot assays, we 
followed the procedures described previously31. The DNA concentration was measured by NanoDrop (Thermo 
Scientific). Briefly, genomic DNA was spotted on nylon membrane (GE Healthcare). The membrane was baked at 
80 °C and then blocked with 5% skimmed milk in TBST for 1 h, followed by the incubation with the anti-5hmC 
antibody (1:5,000; Active Motif) overnight at 4 °C. After washing three times with TBST, then the membranes 
were incubated with POD-labeled secondary antibodies (1:125,000; Roche). Detections were performed using 
BM Chemiluminescence Western Blotting kit (Roche). The densitometry quantification analysis of dot-blot was 
done by Image J software.
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ROS measurement. Cellular ROS levels were detected with dihydroethidium (DHE)50. Cells were incu-
bated with 10 μ M DHE at 37 °C for 30 min, and then cells were rinsed once with PBS and immediately observed 
under fluorescence microscope (LeicaDMI6000B, Leica Microsystems GmbH, Germany) and the photo captured 
were analyzed using Image J software.
Redox-western blot. Cell lysates were prepared using high KCl lysis buffer containing 10 mMTris-HCl, 
pH 8.0, 140 mMNaCl, 300 mMKCl, 1 mM EDTA, 0.5% TritonX-100 and 0.5% sodium deoxycholate with com-
plete protease inhibitor cocktail (Roche) and 20 mM N-ethylmaleimide (NEMI) to block free thiol groups. Equal 
amounts of proteins (30 μ g) were subjected to SDS-PAGE with loading buffer with or without β -mercaptoethanol 
and transferred to polyvinylidene fluoride (PVDF) membranes (Roche). The membranes were treated with 1% 
blocking solution in TBS for 1 h, immunoblots were probed with the indicated antibodies: anti-GFP (1:5,000; 
AbMart, Shanghai, China), anti-Flag (1:5,000; AbMart, Shanghai, China), anti-HA (1:5,000; AbMart, Shanghai, 
China), anti-Prdx-SO3 (1:2,000; Abcam) at 4 °C overnight. Then the membranes were washed and incubated 
with POD-labeled secondary antibodies (1:125,000; Roche). The immunolabeled proteins were detected by BM 
Chemiluminescence Western Blotting kit (Roche).
Microarray data analysis. Human transcriptome array Affymetrix Human HTA2.0 was used in this 
experiment. Affymetrix GeneChip Command Console (version 4.0, Affymetrix) software was used to extract 
raw data. Expression Console (version1.3.1, Affymetrix) software offered RMA normalization. Differentially 
expressed genes were screened out through the fold change. The threshold set for up- and down-regulated 
genes was a fold change greater than or equal to 1.5. For gene expression heat maps, the average expression 
across three replicates in each condition based on the probes with the maximum signal intensity per gene was 
calculated. Heat maps were created using Genesis 1.7.639 based on Pearson correlation coefficients of each 
replicate per condition. Pathway analyses were performed using Gene Set Enrichment Analysis tool v2.0.13 
(GSEA2-2.0.13). The analyses were based on differentially expressed genes in each group. Differential expres-
sion was defined as multiple testing adjusted p values smaller than or equal to 0.05 and fold change greater 
than or equal to 1.5-fold by probes with the maximum intensity in each gene. The enrichment results with 
canonical pathway gene sets C2CP were reported. FDR 25% or less was used to select interesting gene sets for 
hypothesis generation.
Statistical analysis. Data are expressed as mean ± SEM. Statistical comparisons between groups were con-
ducted by unpaired Student’s t-test or one-way ANOVA followed by a Newman-Keuls comparison test. *indicates 
p < 0.05; **indicates p < 0.01; ***indicates p < 0.001. The value of p < 0.05 was considered to be significant.
References
1. Dreaden, E. C., Alkilany, A. M., Huang, X. H., Murphy, C. J. & El-Sayed, M. A. The golden age: gold nanoparticles for biomedicine. 
Chem Soc Rev 41, 2740–2779 (2012).
2. Conde, J. et al. Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine. Front 
Chem. 2, 48 (2014).
3. Luo, Z., Zheng, K. & Xie, J. Engineering ultrasmall water-soluble gold and silver nanoclusters for biomedical applications. Chem 
Commun (Camb) 50, 5143–5155 (2014).
4. Yao, Q. et al. Counterion-assisted shaping of nanocluster supracrystals. Angew Chem Int Ed Engl 54, 184–189 (2015).
5. Yao, Q., Yuan, X., Yu, Y., Xie, J. & Lee, J. Y. Introducing amphiphilicity to noble metal nanoclusters via phase-transfer driven ion-
pairing reaction. J Am Chem Soc 137, 2128–2136 (2015).
6. Goswami, N., Zheng, K. & Xie, J. Bio-NCs–the marriage of ultrasmall metal nanoclusters with biomolecules. Nanoscale 6, 
13328–13347 (2014).
7. Zhang, X. D. et al. Ultrasmall Au(10-12)(SG)(10-12) nanomolecules for high tumor specificity and cancer radiotherapy. Adv Mater 
26, 4565–4568 (2014).
8. Conde, J., Oliva, N. & Artzi, N. Implantable hydrogel embedded dark-gold nanoswitch as a theranostic probe to sense and overcome 
cancer multidrug resistance. Proc Natl Acad Sci USA 112, E1278–E1287 (2015).
9. Conde, J., de la Fuente, J. M. & Baptista, P. V. RNA quantification using gold nanoprobes - application to cancer diagnostics. Journal 
of Nanobiotechnology 8, 1–8 (2010).
10. Braz, A. K. et al. In situ gold nanoparticles formation: contrast agent for dental optical coherence tomography. Journal of biomedical 
optics 17, 066003–066003 (2012).
11. Conde, J., Bao, C., Cui, D., Baptista, P. V. & Tian, F. Antibody–drug gold nanoantennas with Raman spectroscopic fingerprints for 
in vivo tumour theranostics. Journal of Controlled Release 183, 87–93 (2014).
12. Goswami, N. et al. Luminescent Metal Nanoclusters with Aggregation-Induced Emission. J Phys Chem Lett 7, 962–975 (2016).
13. Pan, Y. et al. Size-dependent cytotoxicity of gold nanoparticles. Small 3, 1941–1949 (2007).
14. Zhao, J. Y. et al. Cytotoxicity of nucleus-targeting fluorescent gold nanoclusters. Nanoscale 6, 13126–13134 (2014).
15. Senut, M. C. et al. Size-Dependent Toxicity of Gold Nanoparticles on Human Embryonic Stem Cells and Their Neural Derivatives. 
Small 12, 631–646 (2016).
16. Hauck, T. S., Ghazani, A. A. & Chan, W. C. Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene 
expression in mammalian cells. Small 4, 153–159 (2008).
17. Russo, V. E., Martienssen, R. A. & Riggs, A. D. Epigenetic mechanisms of gene regulation. (Cold Spring Harbor Laboratory Press, 
1996).
18. Bird, A. Perceptions of epigenetics. Nature 447, 396–398 (2007).
19. Berger, S. L., Kouzarides, T., Shiekhattar, R. & Shilatifard, A. An operational definition of epigenetics. Genes & development 23, 
781–783 (2009).
20. Robertson, K. D. DNA methylation and human disease. Nat Rev Genet 6, 597–610 (2005).
21. Szulwach, K. E. et al. 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat Neurosci 14, 
1607–1616 (2011).
22. Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 
324, 930–935 (2009).
23. Ito, S. et al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466, 
1129–1133 (2010).
www.nature.com/scientificreports/
1 2Scientific RepoRts | 6:33436 | DOI: 10.1038/srep33436
24. Lushchak, V. I. Glutathione homeostasis and functions: potential targets for medical interventions. J Amino Acids 2012, 736837 (2012).
25. Singh, S. & Nalwa, H. S. Nanotechnology and health safety–toxicity and risk assessments of nanostructured materials on human 
health. J Nanosci Nanotechnol 7, 3048–3070 (2007).
26. Nel, A., Xia, T., Mädler, L. & Li, N. Toxic potential of materials at the nanolevel. Science 311, 622–627 (2006).
27. Zhang, C. et al. Insights into the Distinguishing Stress-induced Cytotoxicity of Chiral Gold Nanoclusters and the Relationship with 
GSTP1. Theranostics 5, 134 (2015).
28. Wossidlo, M. et al. 5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming. Nat Commun 2, 
241 (2011).
29. Koh, K. P. et al. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem 
cells. Cell Stem Cell 8, 200–213 (2011).
30. He, Y. F. et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333, 1303–1307 (2011).
31. Ito, S. et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333, 1300–1303 (2011).
32. Iyer, L. M., Tahiliani, M., Rao, A. & Aravind, L. Prediction of novel families of enzymes involved in oxidative and other complex 
modifications of bases in nucleic acids. Cell Cycle 8, 1698–1710 (2009).
33. Pastor, W. A., Aravind, L. & Rao, A. TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat 
Rev Mol Cell Bio 14, 341–356 (2013).
34. Conde, J., Oliva, N., Atilano, M., Song, H. S. & Artzi, N. Self-assembled RNA-triple-helix hydrogel scaffold for microRNA 
modulation in the tumour microenvironment. Nat Mater 15, 353–363 (2016).
35. Hahn, M. A. et al. Dynamics of 5-hydroxymethylcytosine and chromatin marks in Mammalian neurogenesis. Cell Rep 3, 291–300 
(2013).
36. Huang, Y. et al. Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells. Proc Natl Acad Sci USA 
111, 1361–1366 (2014).
37. Tevosian, S. G. et al. HBP1: a HMG box transcriptional repressor that is targeted by the retinoblastoma family. Genes & development 
11, 383–396 (1997).
38. Audas, T. E., Li, Y., Liang, G. & Lu, R. A novel protein, Luman/CREB3 recruitment factor, inhibits Luman activation of the unfolded 
protein response. Mol Cell Biol 28, 3952–3966 (2008).
39. Xu, C., Bailly-Maitre, B. & Reed, J. C. Endoplasmic reticulum stress: cell life and death decisions. Journal of Clinical Investigation 115, 
2656 (2005).
40. Tsai, Y.-Y. et al. Identification of the nanogold particle-induced endoplasmic reticulum stress by omic techniques and systems 
biology analysis. ACS nano 5, 9354–9369 (2011).
41. Qiu, J. et al. Id1 induces tubulogenesis by regulating endothelial cell adhesion and cytoskeletal organization through beta1-integrin 
and Rho-kinase signalling. Int J Mol Med 28, 543–548 (2011).
42. Massari, M. E. & Murre, C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol 20, 429–440 
(2000).
43. Norton, J. D. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci 113 (Pt 22), 3897–3905 (2000).
44. Bhattacharya, R., Kowalski, J., Larson, A. R., Brock, M. & Alani, R. M. Id1 promotes tumor cell migration in nonsmall cell lung 
cancers. J Oncol 2010, 856105 (2010).
45. Zou, J., Wang, X., Zhang, L. & Wang, J. Iron nanoparticles significantly affect the in vitro and in vivo expression of Id genes. Chem 
Res Toxicol 28, 373–383 (2015).
46. Fu, H. L. et al. TET1 exerts its tumor suppressor function by interacting with p53-EZH2 pathway in gastric cancer. J Biomed 
Nanotechnol 10, 1217–1230 (2014).
47. Zhao, X. et al. Dynamics of ten-eleven translocation hydroxylase family proteins and 5-hydroxymethylcytosine in oligodendrocyte 
differentiation. Glia 62, 914–926 (2014).
48. Thannickal, V. J. & Fanburg, B. L. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279, L1005–L1028 
(2000).
49. Zhang, C. et al. Glutathione-capped fluorescent gold nanoclusters for dual-modal fluorescence/X-ray computed tomography 
imaging. Journal of Materials Chemistry B 1, 5045–5053 (2013).
50. Mi, Y. J. et al. Amino-Nogo-A antagonizes reactive oxygen species generation and protects immature primary cortical neurons from 
oxidative toxicity. Cell Death Differ 19, 1175–1186 (2012).
51. Chen, K., Mi, Y. J., Ma, Y., Fu, H. L. & Jin, W. L. The mental retardation associated protein, srGAP3 negatively regulates VPA-induced 
neuronal differentiation of Neuro2A cells. Cell Mol Neurobiol 31, 675–686 (2011).
Acknowledgements
The authors thank Dr. Heinrich Leonhardt for generously providing the GFP-tagged TET1-FLand TET1-Δ CXXC 
expression plasmids, Dr. Ross Levine for Flag-TET2, Dr. Toshinobu Nakamura for Flag-TET3, Dr Li-Jung Juan 
for Flag-hTET1, Flag-hTET1-CD mut and Flag-hTET1-Δ CXXC plasmids. pAAV-EF1a-HA-hTET1CD-WPRE-
PolyA was a gift from Hong-jun Song (Addgene plasmid # 39454). This work was supported by National Natural 
Science Foundation of China (Nos 81272801, 81225010, 81472235, and 81327002), National Key Basic Research 
Program of China (“973” Project) (2010CB933901, 2015CB931802) and Shanghai “Science and Technology 
Innovation Action Plan” Basic Research Key Project (No. 12JC1411200).
Author Contributions
W.J., Y.M. and D.C. designed the study. Y.M., S.C., C.Z., J.G. and Z.W. conducted experiments. Y.M., J.C. and H.F. 
analyzed the data and wrote the paper. J.C. revised the manuscript.
Additional Information
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Ma, Y. et al. Chiral Antioxidant-based Gold Nanoclusters Reprogram DNA Epigenetic 
Patterns. Sci. Rep. 6, 33436; doi: 10.1038/srep33436 (2016).
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
 
© The Author(s) 2016
